Morgan Stanley’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $229M | Buy |
1,819,745
+301,508
| +20% | +$37.9M | 0.01% | 817 |
|
2025
Q1 | $168M | Sell |
1,518,237
-55,060
| -3% | -$6.09M | 0.01% | 940 |
|
2024
Q4 | $215M | Buy |
1,573,297
+223,916
| +17% | +$30.6M | 0.02% | 798 |
|
2024
Q3 | $155M | Sell |
1,349,381
-195,488
| -13% | -$22.5M | 0.01% | 960 |
|
2024
Q2 | $213M | Sell |
1,544,869
-520,767
| -25% | -$71.7M | 0.02% | 777 |
|
2024
Q1 | $285M | Sell |
2,065,636
-2,586,952
| -56% | -$357M | 0.02% | 647 |
|
2023
Q4 | $613M | Buy |
4,652,588
+2,728,509
| +142% | +$360M | 0.03% | 588 |
|
2023
Q3 | $216M | Buy |
1,924,079
+56,054
| +3% | +$6.31M | 0.02% | 658 |
|
2023
Q2 | $176M | Buy |
1,868,025
+213,132
| +13% | +$20.1M | 0.02% | 770 |
|
2023
Q1 | $168M | Sell |
1,654,893
-393,192
| -19% | -$39.8M | 0.02% | 773 |
|
2022
Q4 | $245M | Buy |
2,048,085
+1,511,307
| +282% | +$181M | 0.03% | 606 |
|
2022
Q3 | $57M | Buy |
536,778
+49,503
| +10% | +$5.26M | 0.01% | 1228 |
|
2022
Q2 | $47.5M | Buy |
487,275
+310,448
| +176% | +$30.3M | 0.01% | 1407 |
|
2022
Q1 | $16.6M | Buy |
176,827
+37,462
| +27% | +$3.51M | ﹤0.01% | 2328 |
|
2021
Q4 | $11.9M | Sell |
139,365
-5,526
| -4% | -$471K | ﹤0.01% | 2756 |
|
2021
Q3 | $13.9M | Sell |
144,891
-204,709
| -59% | -$19.6M | ﹤0.01% | 2515 |
|
2021
Q2 | $34M | Buy |
349,600
+239,383
| +217% | +$23.3M | ﹤0.01% | 1619 |
|
2021
Q1 | $10.7M | Sell |
110,217
-14,856
| -12% | -$1.44M | ﹤0.01% | 2573 |
|
2020
Q4 | $12M | Sell |
125,073
-158,109
| -56% | -$15.2M | ﹤0.01% | 2318 |
|
2020
Q3 | $27.2M | Buy |
283,182
+137,503
| +94% | +$13.2M | 0.01% | 1257 |
|
2020
Q2 | $17.8M | Buy |
145,679
+64,248
| +79% | +$7.84M | ﹤0.01% | 1503 |
|
2020
Q1 | $7.05M | Sell |
81,431
-78,068
| -49% | -$6.76M | ﹤0.01% | 2117 |
|
2019
Q4 | $17.1M | Buy |
159,499
+76,616
| +92% | +$8.24M | ﹤0.01% | 1802 |
|
2019
Q3 | $7.47M | Buy |
82,883
+24,210
| +41% | +$2.18M | ﹤0.01% | 2433 |
|
2019
Q2 | $4.95M | Sell |
58,673
-30,376
| -34% | -$2.56M | ﹤0.01% | 2926 |
|
2019
Q1 | $7.85M | Sell |
89,049
-67,329
| -43% | -$5.93M | ﹤0.01% | 2278 |
|
2018
Q4 | $11.2M | Sell |
156,378
-57,390
| -27% | -$4.1M | ﹤0.01% | 2014 |
|
2018
Q3 | $26.3M | Buy |
213,768
+117,168
| +121% | +$14.4M | 0.01% | 1441 |
|
2018
Q2 | $9.49M | Sell |
96,600
-88,201
| -48% | -$8.66M | ﹤0.01% | 2435 |
|
2018
Q1 | $15.3M | Buy |
184,801
+133,621
| +261% | +$11.1M | ﹤0.01% | 1927 |
|
2017
Q4 | $3.97M | Buy |
51,180
+14,805
| +41% | +$1.15M | ﹤0.01% | 3341 |
|
2017
Q3 | $2.23M | Sell |
36,375
-16,522
| -31% | -$1.01M | ﹤0.01% | 3771 |
|
2017
Q2 | $2.44M | Buy |
52,897
+22,094
| +72% | +$1.02M | ﹤0.01% | 3627 |
|
2017
Q1 | $1.34M | Sell |
30,803
-16,570
| -35% | -$718K | ﹤0.01% | 4165 |
|
2016
Q4 | $1.83M | Buy |
47,373
+6,605
| +16% | +$255K | ﹤0.01% | 4005 |
|
2016
Q3 | $2.07M | Sell |
40,768
-23,582
| -37% | -$1.19M | ﹤0.01% | 3482 |
|
2016
Q2 | $2.92M | Buy |
64,350
+26,900
| +72% | +$1.22M | ﹤0.01% | 3105 |
|
2016
Q1 | $1.48M | Sell |
37,450
-28,243
| -43% | -$1.12M | ﹤0.01% | 3595 |
|
2015
Q4 | $3.72M | Buy |
65,693
+18,767
| +40% | +$1.06M | ﹤0.01% | 2951 |
|
2015
Q3 | $1.87M | Buy |
46,926
+16,076
| +52% | +$640K | ﹤0.01% | 3578 |
|
2015
Q2 | $1.47M | Sell |
30,850
-73,786
| -71% | -$3.52M | ﹤0.01% | 3901 |
|
2015
Q1 | $4.16M | Buy |
104,636
+6,095
| +6% | +$242K | ﹤0.01% | 2927 |
|
2014
Q4 | $2.2M | Buy |
98,541
+48,368
| +96% | +$1.08M | ﹤0.01% | 3489 |
|
2014
Q3 | $787K | Buy |
50,173
+15,385
| +44% | +$241K | ﹤0.01% | 4248 |
|
2014
Q2 | $516K | Buy |
34,788
+13,668
| +65% | +$203K | ﹤0.01% | 4548 |
|
2014
Q1 | $340K | Sell |
21,120
-28,878
| -58% | -$465K | ﹤0.01% | 4815 |
|
2013
Q4 | $467K | Buy |
49,998
+3,987
| +9% | +$37.2K | ﹤0.01% | 4497 |
|
2013
Q3 | $520K | Sell |
46,011
-23,657
| -34% | -$267K | ﹤0.01% | 4300 |
|
2013
Q2 | $932K | Buy |
+69,668
| New | +$932K | ﹤0.01% | 3778 |
|